AMGN
Amgen IncCompany with tickers: AMGN
CIK
318154
CUSIP
031162100
Shares Outstanding
539,708,274
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $8,618,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | — | ||||
| Research & Development | — | ||||
| Operating Income | $2,666,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| Net Income | $1,819,000,000 | USD | 2026-03-31 | 10-Q | 2026-05-01 |
| EPS (Basic) | $3.37 | USD/shares | 2026-03-31 | 10-Q | 2026-05-01 |
| EPS (Diluted) | $3.34 | USD/shares | 2026-03-31 | 10-Q | 2026-05-01 |